Farther Finance Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5K | Buy |
107
+100
| +1,429% | +$1.4K | ﹤0.01% | 3786 |
|
|
2025
Q1 | $86 | Sell |
7
-28
| -80% | -$344 | ﹤0.01% | 4084 |
|
|
2024
Q4 | $713 | Sell |
35
-72
| -67% | -$1.47K | ﹤0.01% | 3354 |
|
|
2024
Q3 | $3.13K | Buy |
107
+27
| +34% | +$789 | ﹤0.01% | 2824 |
|
|
2024
Q2 | $1.76K | Buy |
80
+45
| +129% | +$991 | ﹤0.01% | 2843 |
|
|
2024
Q1 | $720 | Sell |
35
-49
| -58% | -$1.01K | ﹤0.01% | 2899 |
|
|
2023
Q4 | $1.8K | Buy |
+84
| New | +$1.8K | ﹤0.01% | 2475 |
|